71
Participants
Start Date
February 28, 2015
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Lubiprostone
8 mcg administered orally twice daily (BID)
Placebo
Matching placebo, 0 mcg administered orally twice daily (BID)
Meritus Center for Clinical Research, Hagerstown
Wake Research Associates, LLC, Raleigh
PMG Research of Charlotte, Concord
PMG Research of Charlotte, Charlotte
Cumberland Research Associates, LLC, Fayetteville
Prestige Clinical Research Center, Miami
Advanced Gastroenterology Associates, LLC, Palm Harbor
E Squared Research, Inc., Huntsville
Clinical Research Solutions, Jackson
Mayo Clinic, Rochester
Arkansas Gastroenterology, North Little Rock
Wellness Clinical Research Associates, McKinney
Advanced Clinical Research Associates, Plano
Houston Endoscopy Research Center, Houston
GW Research Inc., Chula Vista
Inland Empire Liver Foundation, Rialto
Collaborators (1)
Takeda
INDUSTRY
Sucampo AG
INDUSTRY
Sucampo Pharma Americas, LLC
INDUSTRY